Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Distribution of drug treatment entrants in Finland 2016, by primary drug

Distribution of drug treatment entrants in Finland in 2016, by primary drug

by Agnete Lundetræ Jürgensen, last edited Jul 17, 2018
Distribution of drug treatment entrants in Finland 2016, by primary drug This statistic shows the distribution of drug treatment entrants in Finland in 2016, by primary drug. That year, opioids was the primary drug used by over 48 percent of Finnish drug treatment entrants. Cannabis had a share of 20 percent, as well as drug treatment entrants that consumed amphetamines as primary drug.
Show more

Distribution of drug treatment entrants in Finland in 2016, by primary drug

Statista Accounts: Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$49 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
paypalgoogleadobepgsamsungtelekom
Statista is a great source of knowledge, and pretty helpful to manage the daily work.
Christof Baron

Christof Baron
CEO, MindShare Germany

Statistics on "Drug use in the Nordic countries"
  • Cannabis
The most important statistics
  • Amphetamines, cocoaine, ecstasy
  • Tobacco
  • Prices
  • Drug treatments
  • Deaths and crime
  • Seizures
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.